🇺🇸 FDA
Patent

US 6689784

Carbamate caspase inhibitors and uses thereof

expired A61PA61P1/04A61P1/16

Quick answer

US patent 6689784 (Carbamate caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/06